In details, ginsenosides Rg3 can regulate cisplatin-induced AKI by regulating PI3K/AKT and NF-κB-mediated apoptosis and inflammatory pathways (Zhang et al. 2021). The gene discussed is AKT1; the disease is acute kidney injury.